Advanced Clinical Research Group LLC — research payments reported

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$286,077	3
2024	Research	$1,821,957	9
2023	Research	$1,729,745	32
2022	Research	$1,151,542	19
2021	Research	$1,223,433	15
2020	Research	$2,029,061	190
2019	Research	$607,437	338

Breakdown

Who paid Research payments · program years 2019–2025

Eisai Inc. $8,835,706 603 payments
Novartis Pharmaceuticals Corporation $12,546 2 payments
Boston Scientific Corporation $1,000 1 payment

Studies the money was for Research payments · program years 2019–2025

A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease $7,448,033 70 payments
A Placebo-Controlled, Double-Blind, Parallel-Group, 24 Month Study With an Open-Label Extension Phase to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Subjects With Early Alzheimer's Disease $1,064,584 511 payments
AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study With an Extension Phase to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer's Disease and Elevated Amyloid (A45 Trial) and in Subjects With Early Preclinical Alzheimer's Disease and Intermediate Amyloid (A3 Trial) $323,090 22 payments
Prospective Comparison of Combined Angiotensin Neprilysin Inhibition With Lcz696 Relative to Enalapril on Central Aortic Stiffness and Ventricular Vascular Coupling in Patients With Heart Failure and Reduced Ejection Fraction $7,499 1 payment
A 52 Week Open Label Evaluation of the Effects of Sacubitril Valsartan Lcz696 Therapy on Biomarkers Myocardial Remodeling and Patient Reported Outcomes in Heart Failure With Reduced Left Ventricular Ejection Fraction $5,047 1 payment
Promus Element Plus $1,000 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.